- Self-BP monitoring (SBPM) with or without guided self-management of antihypertensive therapy was safe and well tolerated, but it did not improve overall BP control in patients with recent stroke or transient ischaemic attack (TIA).
Why this matters
- Rate of BP control in high-risk group, especially in patients with recent stroke, is poor despite the existence of effective treatment options.
- Randomised controlled trial of 154 patients (treatment as usual [TAU], n=52; self-monitoring only [S-MON], n=51; self-monitoring with guided self-management of BP [S-MAN], n=51) with hypertension and a recent stroke or TIA.
- Funding: National Institute for Health Research.
- Mean daytime ambulatory systolic BP at 6 months showed no significant between-group differences (TAU minus S-MON, 2.69 mmHg; 95% CI, −2.59 to 7.97; P=.31; TAU minus S-MAN, 3.00 mmHg (95% CI, −2.53 to 8.54; P=.28) or in mean daytime ambulatory diastolic BP.
- SBPM did not increase the number of participants achieving target BP (daytime ambulatory BP monitoring, ≤120/75 mmHg; P>.05).
- Number of patients with adjusted antihypertensive therapy was higher in the S-MAN group (P=.001) vs TAU group.
- Number of dose increases was higher in the S-MAN group vs TAU group (P≤.0001).
- Small between-group BP difference.